Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

A new portable and wireless device can detect SARS-CoV-2 and vitamin C, a critical nutrient that helps bolster infection ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Low vaccination rates may be contributing to the spread of flu, but data suggests the number of cases so far this season is ...

Maybe you've been in a room recently with someone who's coughing, but they say "I promise it's not COVID." While it's important to still be cautious about COVID-19, there are other viral ...

Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

UConn researchers have identified a novel small molecule for the development of a preventative treatment for a serious and ...

The story of human evolution in ancient past is said to be written in our modern bodies. In his book “Descent of Man,” Charles Darwin talks about vestigial structures. A vestigial structure is a body ...

The spike protein of the coronavirus, or SARS-CoV-2, binds to ACE2, a receptor on the host cells, which allows the virus to enter ... “We simulated the electronic structure of the two interacting ...